MedPath
NMPA Approval

Repaglinide Tablets

国药准字H20217135

December 13, 2021

国药准字H20113380

Drug Information

瑞格列奈片

片剂

1.0mg

化学药品

December 13, 2021

Company Information

Applicant Company

北京市密云区水源西路3号

Manufacturing Company

北京市密云区水源西路3号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

瑞格列奈片 - NMPA 批准文号 | MedPath